How we use evidence.

Clear definitions, primary sources and limits that stay beside the findings.

What these guides are

PeptidesAsia publishes educational source summaries to help readers ask better questions. They are not personalised medical advice, prescribing protocols or a claim that a product is authorised or available.

Source selection

We prioritise official prescribing information, original clinical studies and original laboratory research. For each finding we distinguish the population, preparation, measured outcome and study design. An abstract-only review is identified in the source notes; it is not presented as a full-paper appraisal or a systematic review.

Different evidence answers different questions

A cell or animal experiment can suggest a mechanism without establishing a patient benefit. A study of a named medicine does not automatically validate a compounded preparation, another route or a blend. Source geography does not establish marketing authorisation or delivery coverage.

Editorial ownership and review

These are PeptidesAsia source-based editorial summaries. No individual clinician is named as their medical reviewer, and they should not be read as medically reviewed treatment recommendations. Source-check dates describe the cited material review; publication dates are preserved when a guide is updated.

Corrections and updates

When a material error or new source changes a conclusion, the affected guide and its update date should change. A useful correction identifies the page, disputed statement and primary source. Do not include health records or other sensitive personal information in a general enquiry.

Product names and blends

Catalogue information is kept separate from clinical evidence. Where the supplied catalogue does not state a blend’s ingredients, we explain the uncertainty instead of importing another supplier’s formula.